These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 39112916)
1. Anti-inflammatory and DNA Repair Effects of Astragaloside IV on PC12 Cells Damaged by Lipopolysaccharide. Li HL; Shao LH; Chen X; Wang M; Qin QJ; Yang YL; Zhang GR; Hai Y; Tian YH Curr Med Sci; 2024 Aug; 44(4):854-863. PubMed ID: 39112916 [TBL] [Abstract][Full Text] [Related]
2. [Mechanism of Tongfu Lifei decoction inhibiting the programmed death-1/programmed death-ligand 1 signaling pathway in THP-1 cells by regulating microRNA-146a]. Lyu B; Li L; Huang R; Zhou X; Han L Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Oct; 36(10):1038-1043. PubMed ID: 39586721 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
4. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling. Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689 [TBL] [Abstract][Full Text] [Related]
5. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085 [TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the effect of different doses of human umbilical cord mesenchymal stem cells exosomes on intestinal barrier injury in severely burned rats]. Kang YX; Han SF; Chai W; Zhang Y; Zhang J; Yu HQ; Qian PP; Wang Z; Liu LY Zhonghua Yi Xue Za Zhi; 2024 Dec; 104(45):4153-4161. PubMed ID: 39622747 [No Abstract] [Full Text] [Related]
7. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
9. Serum and urine nucleic acid screening tests for BK polyomavirus-associated nephropathy in kidney and kidney-pancreas transplant recipients. Maung Myint T; Chong CH; von Huben A; Attia J; Webster AC; Blosser CD; Craig JC; Teixeira-Pinto A; Wong G Cochrane Database Syst Rev; 2024 Nov; 11(11):CD014839. PubMed ID: 39606952 [TBL] [Abstract][Full Text] [Related]
10. A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers. Pergolizzi JV; Batra A; Schmidt WK Adv Ther; 2024 Feb; 41(2):659-671. PubMed ID: 38070041 [TBL] [Abstract][Full Text] [Related]
11. Multi-omics PGT: re-evaluation of euploid blastocysts for implantation potential based on RNA sequencing. Jin J; Ma J; Wang X; Hong F; Zhang Y; Zhou F; Wan C; Zou Y; Yang J; Lu S; Tong X Hum Reprod; 2024 Dec; 39(12):2861-2872. PubMed ID: 39413437 [TBL] [Abstract][Full Text] [Related]
12. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs. Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602 [TBL] [Abstract][Full Text] [Related]
13. Icariin Ameliorates D-galactose-induced Cell Injury in Neuron-like PC12 Cells by Inhibiting MPTP Opening. Hu SS; Wang TY; Ni L; Hu FX; Yue BW; Zheng Y; Wang TL; Kumar A; Wang YY; Wang JE; Zhou ZY Curr Med Sci; 2024 Aug; 44(4):748-758. PubMed ID: 38900385 [TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone attenuates lipopolysaccharide-induced acute lung injury via inhibition of NEDD8 activating enzyme. Liu H; Liu Y; Lin X; Fan J; Huang Z; Li A Int Immunopharmacol; 2024 Dec; 143(Pt 3):113605. PubMed ID: 39541844 [TBL] [Abstract][Full Text] [Related]
18. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Bryant A; Hiu S; Kunonga PT; Gajjar K; Craig D; Vale L; Winter-Roach BA; Elattar A; Naik R Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015048. PubMed ID: 36161421 [TBL] [Abstract][Full Text] [Related]
19. Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148 [TBL] [Abstract][Full Text] [Related]